These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 11658838)
1. Philosophical and moral aspects of manipulation and of risk. Sass HM Swiss Biotech; 1987; 5(2a):50-6. PubMed ID: 11658838 [No Abstract] [Full Text] [Related]
2. "Playing God": the ethics of biotechnical intervention. Varga AC Thought; 1985 Jun; 60(237):181-95. PubMed ID: 11651887 [No Abstract] [Full Text] [Related]
5. Recombinant DNA: triumph or Trojan horse? Holtzman E Man Med; 1977; 2(2):83-103, W7. PubMed ID: 12083131 [No Abstract] [Full Text] [Related]
6. Biotechnology and culture: the impact of public debates on government regulation in the United States and Denmark. Baark E; Jamison A Technol Soc; 1990; 12(1):27-44. PubMed ID: 11650912 [No Abstract] [Full Text] [Related]
7. Genetic engineering: the making of monsters? Davis BD Public Interest; 1993; No. 110():63-76. PubMed ID: 11651625 [No Abstract] [Full Text] [Related]
8. The ethics of patenting higher life forms. Hoffmaster B Intellect Prop J; 1988; 4():1-24. PubMed ID: 11652586 [No Abstract] [Full Text] [Related]
9. The regulation of recombinant DNA research: the alternative of local control. Rosenblatt DP Boston Coll Environ Aff Law Rev; 1982; 10(1):37-78. PubMed ID: 11649694 [No Abstract] [Full Text] [Related]
10. State biotechnology oversight: the juncture of technology, law, and public policy. Vito CC Maine Law Rev; 1993; 45(2):329-83. PubMed ID: 11652701 [No Abstract] [Full Text] [Related]
11. The regulation of genetic engineering. Breyer S; Zeckhauser R Man Med; 1975; 1(1):1-12. PubMed ID: 12083123 [No Abstract] [Full Text] [Related]
12. The life sciences and the public: is science too important to be left to the scientist? Goggin ML Politics Life Sci; 1984 Aug; 3(1):28-75. PubMed ID: 11649787 [No Abstract] [Full Text] [Related]
13. Genetic engineering: the moral challenge. Griffin B Hum Life Rev; 1977; 3(3):30-9. PubMed ID: 11662387 [No Abstract] [Full Text] [Related]
14. A case analysis of NEPA implementation: NIH and DNA recombinant research. Chalker SM; Catz RS Duke Law J; 1978 Mar; 1978(1):57-112. PubMed ID: 11661621 [No Abstract] [Full Text] [Related]
16. Germ-line gene therapy: do we need an internatioanl approach? Shapiro D Politics Life Sci; 1994 Aug; 13(2):233-4. PubMed ID: 11654638 [No Abstract] [Full Text] [Related]
17. Bio-medical technology: of the kingdom or of the cosmos? Breck J St Vladmirs Theol Q; 1988; 32(1):5-26. PubMed ID: 11659731 [No Abstract] [Full Text] [Related]
18. Should there be governmental guidelines in bioethics? The French approach. Labrusse-Riou C Boston College Int Comp Law Rev; 1989; 12(1):89-101. PubMed ID: 11659185 [No Abstract] [Full Text] [Related]
19. Recombinant DNA and the regulation of biotechnology: reflections on the Asilomar Conference, ten years after. Barkstrom JE Akron Law Rev; 1985; 19(1):81-126. PubMed ID: 11650740 [No Abstract] [Full Text] [Related]
20. Genetics and the law: a scientist's view. Singer MF Yale Law Policy Rev; 1985; 3(2):315-35. PubMed ID: 11652467 [No Abstract] [Full Text] [Related] [Next] [New Search]